Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.66 USD | +6.09% | +13.76% | +118.82% |
Apr. 19 | North American Morning Briefing : Stock Futures -2- | DJ |
Apr. 04 | ARCA biopharma, Inc. Announces Management Changes | CI |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 24.5M |
---|---|---|---|---|---|
Net income 2022 | -9M | Net income 2023 | -5M | EV / Sales 2022 | - |
Net cash position 2022 | 42.06M | Net cash position 2023 | 37.15M | EV / Sales 2023 | - |
P/E ratio 2022 |
-3.44
x | P/E ratio 2023 |
-4.59
x | Employees | 5 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.71% |
1 day | +1.47% | ||
1 week | +8.49% | ||
Current month | +96.02% | ||
1 month | +94.92% | ||
3 months | +114.29% | ||
6 months | +69.95% | ||
Current year | +102.94% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Keuer
CEO | Chief Executive Officer | 65 | 06-09-30 |
C. Dekker
DFI | Director of Finance/CFO | 60 | 21-05-09 |
Sharon Perry
LAW | General Counsel | - | 07-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anders Hove
BRD | Director/Board Member | 58 | 17-02-15 |
Robert Conway
CHM | Chairman | 70 | 13-09-02 |
Linda Grais
BRD | Director/Board Member | 68 | 07-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 3.72 | +7.83% | 161 718 |
24-04-22 | 3.45 | +1.47% | 294,997 |
24-04-19 | 3.4 | +4.62% | 926,192 |
24-04-18 | 3.25 | +1.25% | 219,431 |
24-04-17 | 3.21 | -1.83% | 95,067 |
Delayed Quote Nasdaq, April 22, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+102.94% | 50.03M | |
+2.49% | 96.73B | |
-1.86% | 21.31B | |
-16.61% | 21.21B | |
-5.80% | 18.79B | |
-42.14% | 16.37B | |
-27.40% | 13.68B | |
+1.44% | 13.44B | |
+21.29% | 10.98B | |
-21.79% | 8.56B |
- Stock Market
- Equities
- ABIO Stock